Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate Immunity

Encoded Library Technology Screening of Hepatitis C Virus NS4B Yields a Small-Molecule Compound Series withIn VitroReplicon Activity

(2015) Christopher Arico-Muendel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Humanized-VHH Transbodies that Inhibit HCV Protease and Replication

(2015) Surasak Jittavisutthikul et al.   Viruses-Basel

Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients

(2015) T Tao et al.   Blood Cancer Journal

Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy

(2014) M. H. Miller et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase

(2014) Kanyarat Thueng-in et al.   mAbs

Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line

(2013) Yizhong Wang et al.   Innate Immunity

Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity

(2013) Aninthita Phalaphol et al.   JOURNAL OF VIROLOGICAL METHODS

How good is automated protein docking?

(2013) Dima Kozakov et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review

(2013) Shuang Wu   WORLD JOURNAL OF GASTROENTEROLOGY

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection

(2012) Jennifer J. Kiser et al.   Annual Review of Pharmacology and Toxicology

Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived from GB Virus A NS5A

(2012) Xiuying Liu et al.   JOURNAL OF VIROLOGY

Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid Protein

(2012) Smitha Kota et al.   PLoS One

Cell Penetrable Humanized-VH/VHH That Inhibit RNA Dependent RNA Polymerase (NS5B) of HCV

(2012) Kanyarat Thueng-in et al.   PLoS One

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

(2012) C. Cooper et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy Minimization

(2011) Dong Xu et al.   BIOPHYSICAL JOURNAL

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atomic-Level Protein Structure Refinement Using Fragment-Guided Molecular Dynamics Conformation Sampling

(2011) Jian Zhang et al.   STRUCTURE

Core as a Novel Viral Target for Hepatitis C Drugs

(2011) Arthur Donny Strosberg et al.   Viruses-Basel

A Human Single Chain Transbody Specific to Matrix Protein (M1) Interferes with the Replication of Influenza A Virus

(2010) Ornnuthchar Poungpair et al.   BIOCONJUGATE CHEMISTRY

Hepatitis C Virus Non-structural Protein 3 (HCV NS3): A Multifunctional Antiviral Target

(2010) Kevin D. Raney et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

(2010) Min Gao et al.   NATURE

I-TASSER: a unified platform for automated protein structure and function prediction

(2010) Ambrish Roy et al.   Nature Protocols

Mixing the right hepatitis C inhibitor cocktail

(2010) Michael A. Gelman et al.   TRENDS IN MOLECULAR MEDICINE

Cyclophilin Inhibitors as a Novel HCV Therapy

(2010) Hengli Tang   Viruses-Basel

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

(2009) Frederic Heitz et al.   BRITISH JOURNAL OF PHARMACOLOGY

Peptide inhibitors of hepatitis C virus core oligomerization and virus production

(2009) S. Kota et al.   JOURNAL OF GENERAL VIROLOGY

1045 SAFETY AND ANTIVIRAL EFFICACY OF 14 DAYS OF THE CYCOPHILIN INHIBITOR NIM811 IN COMBINATION WITH PEGYLATED INTERFERON α2a IN RELAPSED GENOTYPE 1 HCV INFECTED PATIENTS

(2009) E. Lawitz et al.   JOURNAL OF HEPATOLOGY

Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin

(2009) Kasem Kulkeaw et al.   Journal of Proteomics

Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs

(2009) Jean-Michel Pawlotsky   Therapeutic Advances in Gastroenterology

Cell-penetrating peptides: from molecular mechanisms to therapeutics

(2008) May C. Morris et al.   BIOLOGY OF THE CELL

Optimization of the downstream process for high recovery of rhG-CSF from inclusion bodies expressed in Escherichia coli

(2008) Venkata Krishna Rao Dasari et al.   PROCESS BIOCHEMISTRY